Stock markets in India traded a four-day week on a positive note, although monthly futures & options (F&O) expiry did introduce a bit of volatility in the markets. Although there have been no positive developments domestically, market sentiment was boosted by positive global markets. Global shares traded on a positive note following developments overnight regarding the use of Gilead Sciences' antiviral drug Remdesivir as a potential new treatment for COVID-19 patients. Supporting these gains were expectations that India will ease the lockdown following in the steps of Italy, New Zealand and some US states that have lifted some of the restrictions. Lending further support to the positive sentiment in the market was China’s report stating that manufacturing activity in the country expanded slightly in April 2020. Buying was also triggered after Foreign Portfolio Investors (FPIs) turned net buyers of Indian equities on April 29. FPIs bought shares worth a net Rs 722.08 crore on April 29, 2020, as per provisional data released by the stock exchanges. Domestic Institutional Investors (DIIs) bought shares worth a net Rs 78.67 crore on April 29, 2020, as per provisional data.